CONSHOHOCKEN, Pa., May 8, 2025 /PRNewswire/ -- The GBS | CIDP Foundation International is commemorating Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy Awareness Month ...
Want to take a walk or roll to help a global charity find new strides in getting its message out? Then join the “Walk & Roll” for GBS-CIDP, at 10 a.m. Saturday for 1 mile across Conway’s Riverfront ...
The purpose of the Benson Fellowship is to encourage professional training in the peripheral inflammatory neuropathy area for medical doctors, and to encourage philanthropic support to help address ...
Imagine if your body rapidly went weak or if your legs, arms, breathing muscles and face were suddenly paralyzed. That’s what it’s like to have Guillain-Barré (ghee-yan bah-ray) syndrome (GBS), a rare ...
Please provide your email address to receive an email when new articles are posted on . Reasons for misdiagnosis or delayed diagnosis for CIDP are complex and include multiple factors. The FDA ...
GBS-CIDP Foundation International will host a support group meeting for GBS (Guillain-Barre Syndrome) and CIDP patients, their families, caregivers and interested professionals from 10 a.m. until noon ...
The FDA on March 16 approved CSL Behring’s drug Hizentra to treat chronic inflammatory demyelinating polyneuropathy. Hizentra is the first subcutaneous immunoglobulin approved to treat CIDP, a rare ...
Chronic inflammatory demyelinating polyneuropathy (CIDP) may be a rare disease, but it is one of the most common forms of neuropathy and the most common form of chronic autoimmune neuropathy. Roughly ...
CONSHOHOCKEN, Pa., May 8, 2025 /PRNewswire/ -- The GBS | CIDP Foundation International is commemorating Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy Awareness Month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback